|
|
Profile
|
Delegates :
Chikafumi Yokoyama |
|
Incorporated :
February 26 , 2003 |
Paid in Capital :
3809 Million yen as of Dec.2014 |
Employees :
79 人 |
Address :
KDX Shin-yokohama 381 Bldg 9F 3-8-11,Shin-yokohama, Kohoku-ku, Yokohama KANAGAWA
〒222-0033
|
TEL/FAX :
+81-45-475-3887 / +81-45-474-1006 |
URL：
https://www.reprocell.com/en/ |
Attachment :
|
Mission/Background :
Our company is a biotechnology company that aims to contribute to the health and welfare of the people using the technology and The Institute of Medical Science, The University of Tokyo and Institute for Integrated Cell-Material Sciences,Kyoto University. We aim to provide innovative products and services in three areas "Support for Drug Discovery", "Clinical Application (regenerative medicine and Clinical diagnostic services)","research reagents and services" related to ES/iPS cells and stem cells. |
|
Technology & Business
|
Cell culture reagent for human ES/iPS cells; This product was developed by professor Nakatsuji of Kyoto University is the medium for ES cells. In recent year, Prof. Shinya Yamanaka of Kyoto University was established human iPS cells using the medium. We have several reagents of human iPS cells such as a feeder cells and more.
Human iPScell derived cardyomyocyte; Sales of human iPS cell differentiation-induced cells (Cardiomyocyte). Cardiomyocyte can be used to support services of drug discovery, toxicity and metabolism test.
Human iPScell derived Neural cells; Sales of human iPS cell differentiation-induced cells (Neural cells).
Neural stem cells can be used for testing drug screening. Disease models from neural stem cells are expected to be effective in studies of diseases Pathogenesis.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Reagent
|
Others
|
Cellculture reagent for human ES / iPS culture. Human iPS cell derived Neural Cells and cardiomyocytes.
|
Global expansion
|
Drug discovery support
|
Others
|
Drug model cell, Medical device
|
Global expansion
|
Personalized Medicine
|
|
Clinical diagnostic services, Cellbaking
|
|
|
|
|
|
|
|
|
|
|
Highlights
|
●ReproFF and Laminin-5(Laminin-332) launched (July, 2010).
●Human iPS cell-derived Neural Progenitor Cells for Dopaminergic Neuron launched (October, 2010).
●NHK Special "changed man - the future of life Yamanaka iPS cells Revolution" (September 18, 2010)
was introduced in the Company's iPS cell discovery support business.
●Joint research and development with Tokyo Women's Medical University "Development of mass manufacturing system of Human iPS cell-derived cardiomyocyte" since Dec. 2014
|
|
Alliance strategy
|
Joint research・Market expansion・Business partnership
|
|
|